Samrat Pharmachem Ltd.
Snapshot View

726.50 -1.90 ▼-0.3%

25 November 2022, 04:01:00 PM
Volume: 5,035

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.samratpharmachem.com
Market Cap 224.02 Cr.
Enterprise Value(EV) 252.65 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 92.96 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 7.80 Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 200.99 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.61 Calculated using Price: 725.05
Dividend Yield 0.14 Period Ending 2022-03
No. of Shares Subscribed 0.31 Cr. 3,089,700 Shares
FaceValue 10
Company Profile
Samrat Pharmachem was incorporated on June 16, 1992, at Ankleshwar in Gujarat. It was promoted by Lalit Mehta & Rajesh Mehta. The company is currently manufacturing iodine salts & bromine salts. The finished products produced by the company are used in various industries like Pharmaceuticals, Chemicals, Food, Fertilizer, Salt, etc. The products of the company are well received in Indian & foreign markets. The company is a public limited company & its shares are listed & traded on the Bombay Stock Exchange & other bourses of India. The company is presently employing 30 people for its operations at Ankleshwar & Mumbai.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.26%
1 Week
-10.14%
1 Month
-25.02%
3 Month
-3.76%
6 Month
+79.60%
1 Year
+206.54%
2 Year
+542.35%
5 Year
+844.12%
10 Year
+2118.32%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.86 2.38 2.21 12.07 19.01 7.96 19.10 19.77 44.95
Return on Capital Employed (%) 6.93 6.45 5.31 16.40 23.05 11.80 22.43 23.90 52.33
Return on Assets (%) 0.74 1.10 0.97 4.86 8.37 3.79 8.60 9.22 24.20

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 13 13 14 15 19 20 24 30 47 62
Non Curr. Liab. 1 1 2 2 1 1 0 0 0 7
Curr. Liab. 17 12 20 19 21 19 34 27 37 42
Minority Int.
Equity & Liab. 31 26 36 36 41 40 58 57 85 111
Non Curr. Assets 8 8 8 8 8 7 9 10 11 12
Curr. Assets 24 18 28 28 33 33 50 47 74 99
Misc. Exp. not W/O
Total Assets 31 26 36 36 41 40 58 57 85 111

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 66 48 63 73 93 111 137 179 222 273
Other Income 1 0 0 0 0 0 1 0 1 0
Total Income 67 49 63 73 93 112 138 179 222 274
Total Expenditure -66 -47 -62 -69 -87 -108 -131 -170 -197 -233
PBIDT 1 2 1 4 6 4 7 9 25 40
Interest -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation 0 0 0 0 0 0 0 0 -1 -1
Taxation 0 0 0 -1 -2 -1 -2 -2 -6 -10
Exceptional Items 0 0 0 0 0
PAT 0 0 0 2 3 2 4 5 17 29
Adjusted EPS 1 1 1 6 10 5 14 17 56 93

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 4 -1 0 -3 0 2 -1 5 18
Cash Fr. Inv. -1 0 0 -2 1 -2 2 -2 -3 -1
Cash Fr. Finan. 1 -1 0 2 1 2 -4 2 -2 -2
Net Change -2 2 0 0 -1 -1 1 -1 0 14
Cash & Cash Eqvt 0 2 2 4 2 1 2 0 0 15

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 49.13 49.13 49.30 49.30 49.30 49.65 49.65 49.65 49.54
Public 50.87 50.87 50.70 50.70 50.70 50.35 50.35 50.35 50.46
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 24 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
As per requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we enclose herewith copies of advertisement of the Extract of the Standalone Un-Audited Financial Results for the quarter ended September 30 2022 as published in newspapers pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.The advertisement is published in the Baroda Edition of "Indian Express" English Edition & Vadodara Samachar Gujarati Edition on November 15 2022.
Mon, 14 Nov 2022
Board Meeting Outcome for Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2022
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday November 14 2022 the Board has considered and took on record the Un-Audited Standalone Financial Results of the Company for the quarter and half year ended September 30 2022 which is enclosed herewith along with the Statement of Asset & Liabilities Cash Flow Statement and the Limited Review Report of the Statutory Auditor of the Company.The meeting of the Board of Directors of the Company commenced at 14:00 hrs and concluded at 15:30 hrs.
Mon, 14 Nov 2022
Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2022
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday November 14 2022 the Board has considered and took on record the Un-Audited Standalone Financial Results of the Company for the quarter and half year ended September 30 2022 which is enclosed herewith along with the Statement of Asset & Liabilities Cash Flow Statement and the Limited Review Report of the Statutory Auditor of the Company.

Technical Scans View Details >>

Fri, 25 Nov 2022
Closing Below Previous Low Closing Below Previous Low
High Decrease 1 Month High Decrease 1 Month
High Increase 6 Months High Increase 6 Months
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Samrat Pharmachem Ltd.

What is Samrat Pharmachem share price?

Can I buy Samrat Pharmachem shares now?

What is the Dividend Yield of Samrat Pharmachem?

What is the Market Cap of Samrat Pharmachem?

What are the key metrics to analyse Samrat Pharmachem?

What is the 52 Week High and Low of Samrat Pharmachem?

What is the trend of Samrat Pharmachem share price?